Intellectual Property India Publishes Patent Application for 'Differentially Expressed Genes (DEGS) Based Novel Process And Kit For Sepsis Detection' Filed by Nugenica Biotech Labs Private Limited

MUMBAI, India, Oct. 11 -- Intellectual Property India has published a patent application (202441028355 A) filed by Nugenica Biotech Labs Private Limited, Chennai, Tamil Nadu, on April 5, 2024, for 'differentially expressed genes (degs) based novel process and kit for sepsis detection.'

Inventor(s) include Nugenica Biotech Labs Private Limited.

The application for the patent was published on Oct. 10, under issue no. 41/2025.

According to the abstract released by the Intellectual Property India: "The present invention provides a molecular diagnostic method for early detection of sepsis by parallel analysis of host gene expression and pathogen DNA. The method comprises: collecting a peripheral blood sample (100); isolating RNA and DNA (101)...